Go Pro
→ The end of AI data centers coming? (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$5.73
-1.3%		$5.79
$3.36
▼
$6.72
$602.21M0.241.41 million shs961,322 shs
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$9.75
-2.0%		$11.21
$9.62
▼
$21.34
$690.11M-0.0420,958 shs12,158 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
+2.29%-2.52%-3.26%+14.64%+42.56%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
-0.40%-4.69%-10.44%-27.74%-35.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$5.73
-1.3%		$5.79
$3.36
▼
$6.72
$602.21M0.241.41 million shs961,322 shs
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$9.75
-2.0%		$11.21
$9.62
▼
$21.34
$690.11M-0.0420,958 shs12,158 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
+2.29%-2.52%-3.26%+14.64%+42.56%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
-0.40%-4.69%-10.44%-27.74%-35.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
1.50
Reduce$7.3026.85% Upside
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
2.20
Hold$38.67287.25% Upside

Current Analyst Ratings Breakdown

Latest PHAR, ENQ, EGY, and GKP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/23/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$38.00
9/22/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$37.00
9/14/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$37.00
8/7/2026
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
8/7/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
8/3/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$37.00 ➝ $38.00
7/31/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/30/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
(Data available from 10/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$359.27M1.68$1.03 per share5.57$4.25 per share1.35
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$376.13M1.88$0.20 per share49.81$3.95 per share2.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
-$41.39M-$1.06N/A23.98N/A-31.11%-14.36%-6.41%11/9/2026 (Estimated)
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$2.85M$0.1283.2139.94N/A2.51%3.40%1.90%11/5/2026 (Estimated)

Latest PHAR, ENQ, EGY, and GKP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$0.0630$0.02-$0.0430$0.02$99.52 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
$0.254.34%N/AN/A N/A
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
N/AN/AN/AN/AN/A

Latest PHAR, ENQ, EGY, and GKP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2026
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
quarterly$0.06254.22%8/21/20268/21/20269/22/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
0.60
0.44
0.41
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.34
3.01
2.31

Institutional Ownership

CompanyInstitutional Ownership
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
50.32%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.03%

Insider Ownership

CompanyInsider Ownership
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
3.00%
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
2.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Vaalco Energy Inc stock logo
EGY
Vaalco Energy
281105.19 million102.04 millionOptionable
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
40770.78 million69.31 millionNot Optionable

Recent News About These Companies

HC Wainwright Raises Earnings Estimates for Pharming Group
October 2 at 7:26 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-hc-wainwright-raises-earnings-estimates-for-pharming-group-2026-10-02/
Grifols (NASDAQ:GRFS) & Pharming Group (NASDAQ:PHAR) Head to Head Contrast
October 2 at 4:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31077733
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Receives Average Rating of "Hold" from Brokerages
October 2 at 4:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31077714
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Stock Rated "Hold" by Wall Street Analysts
October 2 at 4:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-pharming-group-nv-sponsored-adr-nasdaq-phar-stock-rated-hold-by-wall-street-analysts-2026-10-02/
Q3 EPS Estimates for Pharming Group Boosted by HC Wainwright
October 1 at 6:12 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31073663
Analysts Issue Forecasts for Pharming Group Q3 Earnings
October 1 at 6:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-analysts-issue-forecasts-for-pharming-group-q3-earnings-2026-10-01/
Pharming: Chief Executive Officer Fabrice Chouraqui Steps Down with Immediate Effect
September 30 at 2:32 AM  |  ideal-investisseur.frI
Pharming Appoints Leverne Marsh, Kenneth Lynard as Co-CEOs
September 29 at 4:30 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/pharming-appoints-leverne-marsh-kenneth-073713208.html
Pharmaceutical Executive Daily: Fabrice Chouraqui Steps Down as CEO of Pharming
September 29 at 4:30 PM  |  pharmexec.comP
Pharming Group (NASDAQ:PHAR) Shares Gap Down - Here's What Happened
September 29 at 12:19 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-pharming-group-nasdaq-phar-shares-gap-down-heres-what-happened-2026-09-29/
Pharming Group N.V.: Pharming announces CEO transition
September 29 at 6:29 AM  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-09/69701441-pharming-group-n-v-pharming-announces-ceo-transition-399.htm
Pharming CEO Fabrice Chouraqui Steps Down, Names Leverne Marsh, Kenneth Lynard Interim Co-CEOs
September 29 at 6:29 AM  |  rttnews.comhttps://www.rttnews.com/3694574/pharming-ceo-fabrice-chouraqui-steps-down-names-leverne-marsh-kenneth-lynard-interim-co-ceos.aspx
Pharming CEO Fabrice Chouraqui Resigns After Disagreement on Direction
September 29 at 6:29 AM  |  marketwatch.comhttps://www.marketwatch.com/story/pharming-ceo-fabrice-chouraqui-resigns-after-disagreement-on-direction-da880f04
Pharming announces CEO transition
September 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/29/3370380/0/en/pharming-announces-ceo-transition.html
FDA Accepts Pharming's SNDA For Lower-Dose Joenja In Children With APDS
September 26, 2026  |  rttnews.comhttps://www.rttnews.com/3694043/fda-accepts-pharming-s-snda-for-lower-dose-joenja-in-children-with-apds.aspx
Pharming Group N.V. Announces U.S. FDA Acceptance And Priority Review Of sNDA For Lower Doses Of Joenja To Treat Children With APDS
September 25, 2026  |  marketscreener.comM
Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Time to Buy?
September 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-pharming-group-nasdaq-phar-sees-large-volume-increase-time-to-buy-2026-09-25/
Pharming Says FDA Accepts sNDA for Lower-Dose Joenja in Children With APDS
September 25, 2026  |  marketscreener.comM
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
September 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/25/3369191/0/en/pharming-announces-u-s-fda-acceptance-and-priority-review-of-snda-for-lower-doses-of-joenja-to-treat-children-with-apds.html
Pharming Group's (PHAR) Buy Rating Reaffirmed at HC Wainwright
September 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-pharming-groups-phar-buy-rating-reaffirmed-at-hc-wainwright-2026-09-22/
Pharming Group N.V. Announces Positive Phase II Topline Data For Leniolisib In PIDs With Immune Dysregulation Accepted As Late-Breaking Abstract At ESID 2026
September 22, 2026  |  marketscreener.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Scientist handles blood sample in lab, symbolizing early cancer detection.
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
By Bridget Bennett | September 6, 2026
Palo Alto Networks logo displayed amid a server data center and a digital globe with network connections.
Palo Alto Networks Is Expensive—But Its Growth Is Accelerating
By Thomas Hughes | September 3, 2026
Laptop displaying a stock price chart on a desk, with background TVs showing financial news and a city skyline.
3 Stocks With September Catalysts Investors Shouldn’t Ignore
By Ryan Hasson | September 6, 2026
Rendering of a folded Apple iPhone Duo smartphone concept with dual rear cameras and a desert landscape displayed on screen.
Apple Unveils Foldable iPhone, But Stock's Muted Reaction Raises Questions
By Sam Quirke | September 10, 2026
Illustration of a Bitcoin coin with a declining red candlestick chart in front of the U.S. Capitol building at night.
Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
By Jeffrey Neal Johnson | September 17, 2026
Vaalco Energy stock logo

Vaalco Energy NYSE:EGY

$5.72 -0.08 (-1.29%)
Closing price 03:59 PM Eastern
Extended Trading
$5.80 +0.08 (+1.40%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

VAALCO Energy, Inc., an independent energy company, engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids in Gabon, Egypt, Equatorial Guinea, and Canada. The company holds 58.8% interest in the Etame production sharing contract related to the Etame Marin block covering an area of approximately 46,200 gross acres located offshore in the Republic of Gabon in West Africa. It also owns 100% interest in the Eastern Desert, which contains West Gharib, West Bakr and North West Gharib merged concessions covering as area of approximately 45,067 acres, as well as Western Desert, which contains the South Ghazalat concession covering as area of approximately 7,340 acres located in Egypt. In addition, the company production and working interests in Cardium light oil and Mannville liquids-rich gas assets covering as area of 47,400 gross acres located near the north of Calgary, Alberta; and an undeveloped block offshore Equatorial Guinea, West Africa. VAALCO Energy, Inc. was incorporated in 1985 and is headquartered in Houston, Texas.

Pharming Group stock logo

Pharming Group NASDAQ:PHAR

$9.75 -0.20 (-2.01%)
Closing price 04:00 PM Eastern
Extended Trading
$9.84 +0.09 (+0.87%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas